---
title: "EVANS MICHAEL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/aac47ef3-6abd-5d8b-89eb-0dc22e13cbb1
json: https://whiteintel.dev/api/public/dossier/aac47ef3-6abd-5d8b-89eb-0dc22e13cbb1
identifier: sec:0001312834
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# EVANS MICHAEL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001312834`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/aac47ef3-6abd-5d8b-89eb-0dc22e13cbb1  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/aac47ef3-6abd-5d8b-89eb-0dc22e13cbb1  

## Ownership & control

### Holdings / subsidiaries

- **CHEMOKINE THERAPEUTICS CORP** (director) — https://whiteintel.dev/entity/a160fe3c-c98b-522c-ad55-f5aff7e763e7

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **EVANS MICHAEL**. Human view: https://whiteintel.dev/entity/aac47ef3-6abd-5d8b-89eb-0dc22e13cbb1 · Structured JSON: https://whiteintel.dev/api/public/dossier/aac47ef3-6abd-5d8b-89eb-0dc22e13cbb1._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._